A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Liver Cancer
Related studies linked through entity extraction aliases.
Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
- Status
- COMPLETED
- Phase
- NA
Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
- Status
- COMPLETED
- Phase
- NA
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
- Status
- UNKNOWN
- Phase
- PHASE3
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epirubicin and Thalidomide in Treating Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
T900607 in Treating Patients With Unresectable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
- Status
- COMPLETED
- Phase
- PHASE2